文献速递淋巴瘤

弥漫大B细胞淋巴瘤的遗传学

Genetics of diffuse large B-cell lymphoma.
PubMed 文献 · Blood · 2018-04-17

弥漫大B细胞淋巴瘤(DLBCL)是最常见的淋系恶性肿瘤亚型,约30%患者无法治愈。过去十年基因组技术揭示了其遗传与表观遗传景观,发现大量基因组改变通过破坏生发中心B细胞正常生物学功能参与肿瘤起始与维持。这些发现为改进诊断预后工具及开发靶向治疗策略提供了机会,本综述总结最常见遗传改变及其功能影响与临床意义。

要点

  • DLBCL约30%患者不能治愈,仍为显著临床挑战。
  • 基因组技术揭示大量遗传与表观遗传改变,涉及表观重塑、分化阻滞、免疫逃逸和信号通路组成性激活。
  • 部分突变基因是可操作靶点,正被探索用于新型治疗策略。

核心结论

  • DLBCL的遗传学研究成果为改进诊断和预后工具、指导临床管理提供了独特机会,并推动基于机制的治疗策略开发。

研究设计与样本

  • 综述,总结DLBCL最常见遗传改变及其对恶性转化过程的功能影响和临床意义。

主要发现

  • 约30%的DLBCL患者不能治愈。
  • 已发现的基因组改变涉及表观遗传重塑、分化阻滞、免疫监视逃逸以及多个信号转导通路的组成性激活。
  • 部分已识别的突变基因是潜在可操作靶点,目前正被探索用于开发新型治疗策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diffuse large B-cell lymphoma (DLBCL), the most frequent subtype of lymphoid malignancy, remains a significant clinical challenge, as ∼30% of patients are not cured. Over the past decade, remarkable progress has been made in the understanding of the pathogenesis of this disease, spurred by the implementation of powerful genomic technologies that enabled the definition of its genetic and epigenetic landscape. These studies have uncovered a multitude of genomic alterations that contribute to the initiation and maintenance of the tumor clone by disrupting biological functions known to be critical for the normal biology of its cells of origin, germinal center B cells. The identified alterations involve epigenetic remodeling, block of differentiation, escape from immune surveillance, and the constitutive activation of several signal transduction pathways. This wealth of new information offers unique opportunities for the development of improved diagnostic and prognostic tools that could help guide the clinical management of DLBCL patients. Furthermore, a number of the mutated genes identified are potentially actionable targets that are currently being explored for the development of novel therapeutic strategies. This review summarizes current knowledge of the most common genetic alterations associated with DLBCL in relation to their functional impact on the malignant transformation process, and discusses their clinical implications for mechanism-based therapeutics.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B-cell lymphoma. Blood. 2018. PMID: 29666115. doi:10.1182/blood-2017-11-764332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。